Literature DB >> 9843153

Maturation-dependent apoptotic cell death of oligodendrocytes in myelin-deficient rats.

J B Grinspan1, M Coulalaglou, J S Beesley, D F Carpio, S S Scherer.   

Abstract

Mutations in the proteolipid protein gene (PLP/plp), which encodes the major intrinsic membrane protein in central nervous system (CNS) myelin, cause inherited dysmyelination in mammals. One of these mutants, the myelin-deficient (md) rat, has severe dysmyelination that is associated with oligodendrocyte cell death. Using the terminal deoxynucleotidyl transferase (TdT)-mediated dUTP-biotin nick end-labeling (TUNEL) assay, which labels apoptotic cells, we find that cell death is increased in multiple white matter tracts of md rats. The tracts that myelinate the earliest show the earliest increase in cell death, and cell death persists for at least 22 days, the lifespan of these mutant animals. In all tracts, and at all developmental ages examined, apoptotic cells expressed the markers of mature oligodendrocytes, such as myelin basic protein, myelin-associated glycoprotein, and the Rip antigen, but not chondroitin sulfate proteoglycan, a marker of oligodendrocyte precursors. Mature oligodendrocytes fail to accumulate in md brain because they die before they fully mature.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9843153     DOI: 10.1002/(SICI)1097-4547(19981201)54:5<623::AID-JNR7>3.0.CO;2-R

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  10 in total

1.  Genetic analyses demonstrate that bone morphogenetic protein signaling is required for embryonic cerebellar development.

Authors:  Lihua Qin; Lara Wine-Lee; Kyung J Ahn; E Bryan Crenshaw
Journal:  J Neurosci       Date:  2006-02-15       Impact factor: 6.167

2.  BMP signaling mutant mice exhibit glial cell maturation defects.

Authors:  Jill See; Polina Mamontov; Kyung Ahn; Lara Wine-Lee; E Bryan Crenshaw; Judith B Grinspan
Journal:  Mol Cell Neurosci       Date:  2007-02-23       Impact factor: 4.314

Review 3.  Connexins-mediated glia networking impacts myelination and remyelination in the central nervous system.

Authors:  Tao Li; Christian Giaume; Lan Xiao
Journal:  Mol Neurobiol       Date:  2014-01-07       Impact factor: 5.590

4.  Endpoints in myelin-deficient (MD) rats.

Authors:  Jacek M Kwiecien; Kathleen H Delaney
Journal:  Comp Med       Date:  2010-10       Impact factor: 0.982

5.  Elevated levels of the chemokine GRO-1 correlate with elevated oligodendrocyte progenitor proliferation in the jimpy mutant.

Authors:  Q Wu; R H Miller; R M Ransohoff; S Robinson; J Bu; A Nishiyama
Journal:  J Neurosci       Date:  2000-04-01       Impact factor: 6.167

6.  Oxidative stress disrupts oligodendrocyte maturation.

Authors:  Heather Morein French; Mary Reid; Polina Mamontov; Rebecca A Simmons; Judith B Grinspan
Journal:  J Neurosci Res       Date:  2009-11-01       Impact factor: 4.164

7.  Clemastine effects in rat models of a myelination disorder.

Authors:  Christopher A Turski; Gabrielle N Turski; Bingming Chen; Hauhui Wang; Moones Heidari; Lingjun Li; Kevin K Noguchi; Cara Westmark; Ian Duncan; Chrysanthy Ikonomidou
Journal:  Pediatr Res       Date:  2018-05-02       Impact factor: 3.756

8.  Genetic dysmyelination alters the molecular architecture of the nodal region.

Authors:  Edgardo J Arroyo; Theodore Xu; Judith Grinspan; Stephen Lambert; S Rock Levinson; Peter J Brophy; Elior Peles; Steven S Scherer
Journal:  J Neurosci       Date:  2002-03-01       Impact factor: 6.167

9.  PLP1 Mutations in Patients with Multiple Sclerosis: Identification of a New Mutation and Potential Pathogenicity of the Mutations.

Authors:  Nancy C Cloake; Jun Yan; Atefeh Aminian; Michael P Pender; Judith M Greer
Journal:  J Clin Med       Date:  2018-10-11       Impact factor: 4.241

Review 10.  Neuro-glial interactions at the nodes of Ranvier: implication in health and diseases.

Authors:  Catherine Faivre-Sarrailh; Jérôme J Devaux
Journal:  Front Cell Neurosci       Date:  2013-10-29       Impact factor: 5.505

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.